
feeds.newsfilecorp.com
Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
Toronto, Ontario--(Newsfile Corp. - March 2, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a
Loading news...

Toronto, Ontario--(Newsfile Corp. - March 2, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a

Toronto, Ontario--(Newsfile Corp. - February 2, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage